
|Articles|August 1, 2006
Eye on Washington
Advertisement
August in the nation’s capital is, as always, hot, hot, hot-and members of Congress would nodoubt rather be anywhere else. At present, however, concerns over how to constrain some ofthe administration’s anti-terrorist activities in the interest of preserving civil liberties and createreasonable, enforceable immigration regulations keep them hard at work.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
2
Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV
3
FDA approves powder formulation of trofinetide for Rett syndrome
4
FDA approves Waskyra as first gene therapy for Wiskott-Aldrich syndrome
5








